Blockchain Workgroup Meeting Project Evaluating how Blockchain can
Blockchain Workgroup Meeting Project: Evaluating how Blockchain can transform the Pharmaceutical and Healthcare industry 10 Jan 2018
Agenda 1. 2. 3. 4. 5. 6. 7. 8. Welcome Project members Sub-Workgroups Project delivery Project team roles Current goals Project Timelines Conferences, posters, etc.
Project members • • Co-leads: – Disa Lee Choun (UCB) – Adama Ibrahim (Biogen) – Christopher Hart (Manchester Informatics Limited) Members: – Hariprasad Radhakrishnan (Astra. Zeneca) – Eric Wu (Gilead) – Anders Bergkvist (Merck) – Aji Barot (Health. Unlocked) – Fernand Maes (Johnson & Johnson) – Will Ivy (Johnson & Johnson) – Zakaria Arrassi (UCB) – Marc Casals (UCB) – – – – 26 Project Members! Yusuf Ghadiali (Biogen) Imran Shakur (Biogen) Mayur Joshi (Biogen) Richard Shute (Curlew Research) Bob Clay (Highbury Regulatory) Matt Mc. Clain (Lilly) Kenneth Ng (Hashed Health) Philip Clothiaux (Hashed Health) Kenneth Getz (Tufts University) Loretis Alisauskas (IBM) Selina Lee (IBM) Nicole Tay (Mercantis) Jim Nasr (CDC, Acoer) Karin Beckstrom (ERT) Maria Palombini (IEEE)
Project Deliverable Timelines • Provide a white paper that: • Researching Blockchain and • Includes an overview of Block. Chain implementation details: 3 months • Analyses the current process and • Finalising the whitepaper: 6 -9 areas where Block. Chain would have months most impact (i. e. efficiency, change management, …) • Proposes Use Cases where Blockchain would transform the current landscape Communication plan: Publication, presentation, and webinars Propose presentation • DIA in June 2018 • Ph. USE Conference in June 2018 • Others (tbd)
Sub-workgroup • Group 1. Introduce Block. Chain and describe how it works, what are the benefits, etc. + high level use case to explain the technology. – Sub Group Leader: Aji • Group 2. Pre-requisites to adopt Block. Chain: Regulatory/FDA statement, IT and Pharma/Healthcare landscape, "are we ready for blockchain" – Sub Group Leader: Chris • Group 3. Understand the qualities of Block. Chain relevant to the i. e. 2 chosen use cases. Provide high level analysis of Pros/Cons – Sub Group Leader: Adama
Project team roles: • Contributors • Advisers • Reviewers Editors: • Disa, Adama, Aji, Chris Chief Editor: • Disa
Current goals • • Add essential content to sections Craft compelling messages Ruthlessly edit sections – aiming for <20 pp Create action-packed executive summary
Project timelines Milestone Timeline Kick off Meeting Sept 2017 Sub Group Formation Sept 2017 Sub Section Headings (Phuse Template) Oct 2017 100 words for Ph. USE presentation Nov 2017 Decide on Use Cases Nov 2017 Contributors to work on the specific sections and consolidate in one document Dec 201711 Jan 2018 WG Co-leads and SWG leads review and send draft for Project team review Dec 201715 Jan 2018 Review Cycle 1 (2 weeks turnaround) by Project team 26 Jan 2018 WG Co-leads and SWG leads review and complete the document (add/remove any sections and work with specific SME members as needed) 16 Feb 2018 Review Cycle 2 – Final Team Review (2 weeks turnaround) by Project team Feb 201802 Mar 2018 WG Co-leads and SWG leads Group finalise the document Feb 201816 Mar 2018 Send for PHUSE/Independent Review 16 March 2018 WG Co-leads and SWG leads Group to update and finalise document for publishing April 2018 WG members to work/finalise presentation slides for conferences April 2018
Conferences, Posters, etc. • • • IEEE Feb (Orlando)- Presentation/Roundtable discussion: Adama Global Clinical Trials Connect, Apr (London) – Presentation: Disa + Blockchain in Healthcare, May (London)- Presentation: Disa + DIA Jun (Boston)- Poster session: Adama + Ph. USE Jun (Raleigh)- Presentation: Disa + Clinical Innovation Partnerships (Zurich) – Panel discussion: Chris Publications: • Ph. USE • Any other?
Thank you
- Slides: 10